[HTML][HTML] Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application

Y Fan, Z Yang - Pharmaceutics, 2022 - mdpi.com
The development of siRNA technology has provided new opportunities for gene-specific
inhibition and knockdown, as well as new ideas for the treatment of disease. Four siRNA …

[HTML][HTML] Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application

Y Fan, Z Yang - Pharmaceutics, 2022 - ncbi.nlm.nih.gov
The development of siRNA technology has provided new opportunities for gene-specific
inhibition and knockdown, as well as new ideas for the treatment of disease. Four siRNA …

Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application

Y Fan, Z Yang - Pharmaceutics, 2022 - pubmed.ncbi.nlm.nih.gov
The development of siRNA technology has provided new opportunities for gene-specific
inhibition and knockdown, as well as new ideas for the treatment of disease. Four siRNA …

Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application.

Y Fan, Z Yang - Pharmaceutics, 2022 - search.ebscohost.com
The development of siRNA technology has provided new opportunities for gene-specific
inhibition and knockdown, as well as new ideas for the treatment of disease. Four siRNA …

Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application

Y Fan, Z Yang - Pharmaceutics, 2022 - search.proquest.com
The development of siRNA technology has provided new opportunities for gene-specific
inhibition and knockdown, as well as new ideas for the treatment of disease. Four siRNA …

Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application.

Y Fan, Z Yang - Pharmaceutics, 2022 - europepmc.org
The development of siRNA technology has provided new opportunities for gene-specific
inhibition and knockdown, as well as new ideas for the treatment of disease. Four siRNA …